Peptidomics of Cancer-Derived Enzyme Products

The latest volume in the ongoing The Enzymes series focuses on the analysis of enzymes for early cancer diagnosis

Tony Y. Hu (Volume editor), Fuyuhiko Tamanoi (Volume editor)

9780128126387, Elsevier Science

Hardback, published 18 October 2017

188 pages
22.9 x 15.1 x 1.9 cm, 0.48 kg

Peptidomics of Cancer-Derived Enzyme Products, Volume 42, the latest in The Enzymes series, is ideal for researchers in biochemistry, molecular and cell biology, pharmacology, and cancer, with this volume featuring high-caliber, thematic articles on the topic of peptidomics of cancer-derived enzyme products. Specific chapters cover Circulating peptidome and tumor-resident proteolysis, Colon tumor secretopeptidome, Chemoenzymatic method for glycomics, Human plasma peptidome for pancreatic cancer, Lipoproteomics and quantitative proteomics, Salivaomics: Protein markers/extracellular RNA/DNA in saliva, and Enzyme-responsive vectors for cancer therapy.

1. Overview of this volume
2. Circulating peptidome and tumor-resident proteolysis
3. Colon tumor secretopeptidome
4. Chemoenzymatic method for glycomics
5. Human plasma peptidome for pancreatic cancer
6. Lipoproteomics and quantitative proteomics
7. Salivaomics: Protein markers/extracellular RNA/DNA in saliva
8. Enzyme-responsive vectors for cancer therapy

Subject Areas: Molecular biology [PSD], Enzymology [PSBZ], DNA & Genome [PSAK1], Pharmacology [MMG], Oncology [MJCL]